Blackstone’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Blackstone's UTHR Position: Q2 2026 in Review
Blackstone opened a new position in United Therapeutics (UTHR) in Q2 2026: 1,813 shares worth $982K. The stake represents ﹤0.01% of the portfolio and ranks #260 among its holdings. This is a return to the name: Blackstone previously reported a position in UTHR as recently as Q1 2019.
Blackstone first reported a position in UTHR in Q1 2019 and has held it in 2 quarters since. The position peaked at $6.55M in Q1 2019. 887 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Blackstone held 1,813 shares of United Therapeutics worth $982K as of Q2 2026.
- United Therapeutics was a new Blackstone position in Q2 2026.
- United Therapeutics made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #260 holding.
- Blackstone first reported a position in United Therapeutics in Q1 2019 and has held it in 2 quarters since.
- Blackstone's United Therapeutics position peaked at $6.55M in Q1 2019.
- 887 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.